Perbedaan Lionmesh Prima Tbk. dan Organon Pharma Indonesia Tbk.: Lionmesh Prima Tbk. diperdagangkan di Rp256 (kapitalisasi pasar 24,58 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. jauh lebih besar — sekitar 4,2× kapitalisasi pasar Lionmesh Prima Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| LMSH | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 24,58 M | 104,4 M |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Lionmesh Prima Tbk (the Company) was originally under the name PT Lion Weldmesh Prima and established on December 14, 1982. The Company its started commercial operations in 1984.
Selengkapnya di halaman LMSH →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →